This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Tuesday's Small-Cap Winners & Losers

Small-cap stocks trailed the rest of the market Tuesday, but among these, a few health care names excelled nonetheless.

For instance, New Jersey's Pharmos (PARS) was one of today's best-performing stocks overall, surging 37.3% after its cannabinor treatment achieved the primary endpoint of a phase IIa trial. The cannabinoid -- a synthetic compound chemically related to marijuana -- yielded statistically significant results in post-operative pain relief. Shares gained 56 cents to $2.06.

Symbion (SMBI) vaulted 17.9% to $22.43 after the Nashville, Tenn., surgical-facilities operator agreed to sell itself to private-equity firm Crestview Partners for $22.35 a share. The $637 million deal (including debt assumption) should close in the third quarter. And biotech Halozyme Therapeutics (HTI) shares leapt 11.1% to $9.94 after the company agreed to sell 3.5 million newly minted company shares to New River Management at a premium of $9.17 apiece.

Elsewhere, California's Irvine Sensors (IRSN) surged 27.3% to $1.68 after its Optex Systems unit received more than $9 million in new orders for its military optical systems. These should begin shipping in the second half of fiscal 2007. Firearms maker Sturm, Ruger & Co. (RGR - Get Report) climbed 11.5% to $13.44 after first-quarter income ratcheted up more than sevenfold from last year to 36 cents a share, or $8.1 million.

Volterra Semiconductor (VLTR), meanwhile, gained 10.8% to $16.44 after first-quarter earnings added a penny on last year to 7 cents a share, squaring with Wall Street targets, according to Thomson Financial. House of Taylor Jewelry (HOTJ), based in West Hollywood, Calif., brought in more than six times higher fourth-quarter 2006 sales year over year. Shares leapt 7.6% to $2.40.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
VLTR $22.97 -0.13%
PARS $0.07 0.00%
RGR $54.46 0.00%
AAPL $124.75 0.00%
FB $80.78 0.00%

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs